Your browser doesn't support javascript.
loading
Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland.
Maguire, Barrie; Blake, Ophelia; Boran, Gerard; Borovickova, Ingrid; Abdelfadil, Sabah; Murray, Caroline; Elnazir, Basil; Linnane, Barry.
Afiliación
  • Maguire B; University of Dublin Trinity College, Dublin, Ireland; University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • Blake O; University Hospital Limerick, Dooradoyle, Limerick, Ireland.
  • Boran G; University of Dublin Trinity College, Dublin, Ireland; Tallaght University Hospital, Dublin, Ireland.
  • Borovickova I; Children's Health Ireland at Temple Street and Crumlin Hospitals, Dublin, Ireland.
  • Abdelfadil S; Children's Health Ireland at Temple Street and Crumlin Hospitals, Dublin, Ireland.
  • Murray C; Tallaght University Hospital, Dublin, Ireland.
  • Elnazir B; Tallaght University Hospital, Dublin, Ireland.
  • Linnane B; School of Medicine and Centre for Interventions in Infection, Inflammation and Immunity (4i), University of Limerick, Limerick, Ireland; National Children's Research Centre, Crumlin, Dublin, Ireland. Electronic address: barry.linnane@hse.ie.
J Cyst Fibros ; 21(3): 416-421, 2022 05.
Article en En | MEDLINE | ID: mdl-34620573
BACKGROUND: The sweat test has been the "gold standard" diagnostic test for cystic fibrosis for more than 40 years. We hypothesized that there would be a change in the pattern of sweat testing in Ireland since the introduction of cystic fibrosis newborn screening in 2011, when practices were last reviewed. This is a follow up survey looking at sweat testing numbers and practices. METHODS: A national survey compiled data on sweat collection, conductivity and sweat chloride testing in all hospitals previously identified as performing sweat tests. RESULTS: All 13 centres in Ireland performing sweat testing in 2018 responded to the survey (100% return rate). Our results indicate that 1007 sweat tests were performed in 2018 compared to 2555 in 2011, equating to a 61% reduction. Seven out of 13 centres are performing less than 50 sweat tests per year. Nine out of 13 centres (69%) had a sweat test failure rate greater than the recommended allowable rate of ≤ 10%. We detected a trend of sweat testing in patients with an existing diagnosis of CF who had commenced cystic fibrosis transmembrane conductance regulator (CFTR) modulators. CONCLUSIONS: There has been a significant reduction in the number of sweat tests performed in Ireland since the introduction of newborn screening for CF. There remains a lack of standardisation in many aspects of the service ranging from sample collection to reporting of results. We have identified a new trend of sweat testing in the cystic fibrosis transmembrane conductance regulator modulator era.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Newborn País/Región como asunto: Europa Idioma: En Revista: J Cyst Fibros Año: 2022 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans / Newborn País/Región como asunto: Europa Idioma: En Revista: J Cyst Fibros Año: 2022 Tipo del documento: Article País de afiliación: Irlanda
...